Xencor, Inc.
US ˙ NasdaqGM ˙ US98401F1057

Pendahuluan

Halaman ini memberikan analisis komprehensif tentang sejarah perdagangan orang dalam yang diketahui dari Todd E Simpson. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Adalah ilegal bagi orang dalam untuk melakukan perdagangan di perusahaan mereka berdasarkan informasi spesifik yang tidak dipublikasikan. Ini tidak berarti bahwa mereka dilarang melakukan perdagangan apa pun di perusahaan mereka sendiri. Namun, mereka harus melaporkan semua perdagangan kepada SEC melalui Formulir 4. Terlepas dari pembatasan ini, penelitian akademis menunjukkan bahwa orang dalam - secara umum - cenderung mengungguli pasar di perusahaan mereka sendiri.

Rata-rata Profitabilitas Perdagangan

Profitabilitas perdagangan rata-rata adalah pengembalian rata-rata dari semua pembelian pasar terbuka yang dilakukan oleh orang dalam dalam tiga tahun terakhir. Untuk menghitung ini, kami memeriksa setiap pembelian pasar terbuka yang tidak direncanakan yang dilakukan oleh orang dalam, tidak termasuk semua perdagangan yang ditandai sebagai bagian dari rencana perdagangan 10b5-1. Kami kemudian menghitung kinerja rata-rata dari perdagangan tersebut selama 3, 6, dan 12 bulan, dengan merata-ratakan setiap durasi tersebut untuk menghasilkan metrik kinerja akhir untuk setiap perdagangan. Terakhir, kami merata-ratakan semua metrik kinerja untuk menghitung metrik kinerja untuk orang dalam. Daftar ini hanya mencakup orang dalam yang telah melakukan setidaknya tiga perdagangan dalam dua tahun terakhir.

Jika profitabilitas perdagangan orang dalam ini adalah "N/A", maka orang dalam tersebut belum melakukan pembelian di pasar terbuka dalam tiga tahun terakhir, atau perdagangan yang mereka lakukan terlalu baru untuk menghitung metrik kinerja yang andal.

Frekuensi Pembaruan: Setiap Hari

Lihat daftar pedagang dalam perusahaan yang paling menguntungkan.

Perusahaan dengan Posisi Orang Dalam yang Dilaporkan

Pengajuan SEC menunjukkan bahwa Todd E Simpson telah melaporkan kepemilikan atau perdagangan di perusahaan-perusahaan berikut:

Keamanan Judul Kepemilikan Terakhir yang Dilaporkan
US:XNCR / Xencor, Inc. Director 13,686
US:SGEN / Seagen Inc Chief Financial Officer 0
US:NLTX / Neoleukin Therapeutics, Inc. Director 25,000
Cara Membaca Grafik

Grafik berikut menunjukkan kinerja saham sekuritas setelah setiap perdagangan pasar terbuka yang tidak direncanakan yang dilakukan oleh Todd E Simpson. Perdagangan yang tidak direncanakan adalah perdagangan yang tidak dilakukan sebagai bagian dari rencana perdagangan 10b5-1. Kinerja saham digambarkan sebagai perubahan persentase kumulatif dalam harga saham. Misalnya, jika perdagangan orang dalam dilakukan pada 1 Januari 2019, grafik akan menunjukkan perubahan persentase harian sekuritas hingga saat ini. Jika harga saham naik dari $10 menjadi $15 selama periode ini, perubahan persentase kumulatif dalam harga saham akan menjadi 50%. Perubahan harga dari $10 menjadi $20 akan menjadi 100%, dan perubahan harga dari $10 menjadi $5 akan menjadi -50%.

Pada akhirnya, kita mencoba menentukan seberapa erat korelasi perdagangan orang dalam dengan pengembalian berlebih (positif atau negatif) pada harga saham untuk melihat apakah orang dalam tersebut mengatur waktu perdagangannya untuk mendapatkan keuntungan dari informasi orang dalam. Pertimbangkan situasi di mana orang dalam melakukan hal ini. Dalam situasi ini, kita akan mengharapkan (a) pengembalian positif setelah pembelian, atau (b) pengembalian negatif setelah penjualan. Dalam kasus (a), grafik PEMBELIAN akan menunjukkan serangkaian kurva yang miring ke atas, menunjukkan pengembalian positif setelah setiap transaksi pembelian. Dalam kasus (b), grafik PENJUALAN akan menunjukkan serangkaian kurva yang miring ke bawah, menunjukkan pengembalian negatif setelah setiap transaksi penjualan.

Namun, ini saja tidak cukup untuk menarik kesimpulan. Jika, misalnya, harga saham perusahaan berada dalam tren kenaikan non-siklikal selama bertahun-tahun, maka kita akan mengharapkan semua plot pasca-pembelian memiliki kemiringan ke atas. Demikian pula, penurunan non-siklikal selama bertahun-tahun akan menghasilkan plot pasca-perdagangan dengan kemiringan ke bawah. Tak satu pun dari grafik ini akan menunjukkan aktivitas perdagangan orang dalam.

Indikator terkuat adalah situasi di mana harga saham sangat siklikal, dan terdapat sinyal positif pada grafik PEMBELIAN dan plot negatif pada grafik PENJUALAN. Situasi ini akan sangat menunjukkan adanya orang dalam yang mengatur waktu perdagangan untuk keuntungan finansial mereka.

Pembelian Orang Dalam XNCR / Xencor, Inc. - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di XNCR / Xencor, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

XNCR / Xencor, Inc. Insider Trades
Penjualan Orang Dalam XNCR / Xencor, Inc. - Analisis Kerugian Jangka Pendek

Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di XNCR / Xencor, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

XNCR / Xencor, Inc. Insider Trades
Sejarah Perdagangan Orang Dalam

Tabel ini menunjukkan daftar lengkap transaksi orang dalam yang dilakukan oleh Todd E Simpson sebagaimana diungkapkan kepada Komisi Bursa Efek (Securities Exchange Commission/SEC).

Tanggal File Tanggal Transaksi Formulir Ticker Keamanan Kode 10b5-1 Saham Sisa Saham Persen
Ubah
Bagikan
Harga
Tran
Nilai
Sisa
Nilai
2025-06-16 2025-06-12 4 XNCR Xencor Inc
Common Stock
A - Award 13,686 13,686
2023-12-15 2023-12-14 4 SGEN Seagen Inc.
Common Stock
D - Sale to Issuer -93,292 0 -100.00 229.00 -21,363,868
2023-09-22 2023-09-21 4 SGEN Seagen Inc.
Common Stock
S - Sale X -80 128,723 -0.06 206.50 -16,520 26,581,300
2023-09-01 2023-08-31 4 SGEN Seagen Inc.
Common Stock
S - Sale X -2,122 128,803 -1.62 206.97 -439,182 26,657,829
2023-08-30 2023-08-29 4 SGEN Seagen Inc.
Common Stock
S - Sale X -485 130,925 -0.37 206.00 -99,910 26,970,550
2023-08-30 2023-08-28 4 SGEN Seagen Inc.
Common Stock
A - Award 1,225 131,410 0.94
2023-08-17 2023-08-16 4 SGEN Seagen Inc.
Common Stock
D - Sale to Issuer X -1,540 130,185 -1.17 193.87 -298,558 25,238,823
2023-08-17 2023-08-16 4 SGEN Seagen Inc.
Common Stock
D - Sale to Issuer X -861 131,725 -0.65 193.87 -166,921 25,537,381
2023-08-17 2023-08-16 4 SGEN Seagen Inc.
Common Stock
D - Sale to Issuer X -1,106 132,586 -0.83 193.87 -214,419 25,704,302
2023-08-17 2023-08-15 4 SGEN Seagen Inc.
Common Stock
A - Award 14,746 133,692 12.40
2023-04-12 2023-04-10 4 SGEN Seagen Inc.
Common Stock
S - Sale X -40,364 118,946 -25.34 204.74 -8,264,125 24,353,004
2023-04-12 2023-04-10 4 SGEN Seagen Inc.
Common Stock
M - Exercise 40,364 159,310 33.93 46.37 1,871,679 7,387,205
2023-04-12 2023-04-10 4 SGEN Seagen Inc.
Common Stock
S - Sale X -14,980 118,946 -11.19 204.14 -3,058,017 24,281,636
2023-04-12 2023-04-10 4 SGEN Seagen Inc.
Common Stock
M - Exercise 14,980 133,926 12.59 46.37 694,623 6,210,149
2023-04-07 2023-04-06 4 SGEN Seagen Inc.
Common Stock
S - Sale X -243 118,946 -0.20 205.86 -50,023 24,485,819
2023-04-07 2023-04-05 4 SGEN Seagen Inc.
Common Stock
A - Award 609 119,189 0.51
2023-04-04 2023-04-01 4 SGEN Seagen Inc.
Common Stock
A - Award 1,395 118,580 1.19
2023-03-10 2023-03-09 4 SGEN Seagen Inc.
Common Stock
S - Sale X -6,082 117,185 -4.93 177.37 -1,078,764 20,785,103
2023-03-10 2023-03-09 4 SGEN Seagen Inc.
Common Stock
S - Sale X -26,449 123,267 -17.67 176.71 -4,673,803 21,782,512
2023-03-10 2023-03-09 4 SGEN Seagen Inc.
Common Stock
S - Sale X -10,262 149,716 -6.41 175.89 -1,804,983 26,333,547
2023-03-10 2023-03-09 4 SGEN Seagen Inc.
Common Stock
M - Exercise 42,793 159,978 36.52 45.30 1,938,523 7,247,003
2023-02-28 2023-02-27 4 SGEN Seagen Inc.
Common Stock
S - Sale X -20,000 117,185 -14.58 182.53 -3,650,600 21,389,778
2023-02-21 2023-02-16 4 SGEN Seagen Inc.
Common Stock
S - Sale X -39,946 137,185 -22.55 160.00 -6,391,400 21,949,737
2023-02-21 2023-02-16 4 SGEN Seagen Inc.
Common Stock
M - Exercise 39,946 177,131 29.12 39.15 1,563,886 6,934,679
2022-09-01 2022-08-31 4 SGEN Seagen Inc.
Common Stock
S - Sale X -2,064 137,185 -1.48 154.41 -318,712 21,183,353
2022-09-01 2022-08-31 4 SGEN Seagen Inc.
Common Stock
S - Sale X -2,122 139,249 -1.50 154.41 -327,668 21,502,065
2022-08-17 2022-08-16 4 SGEN Seagen Inc.
Common Stock
S - Sale X -1,106 141,371 -0.78 170.22 -188,258 24,063,479
2022-08-17 2022-08-16 4 SGEN Seagen Inc.
Common Stock
S - Sale X -861 142,477 -0.60 170.22 -146,555 24,251,737
2022-08-17 2022-08-15 4 SGEN Seagen Inc.
Common Stock
A - Award 15,447 143,338 12.08
2022-05-16 2022-05-12 4 NLTX Neoleukin Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 25,000 25,000
2022-04-22 2022-04-20 4 SGEN Seagen Inc.
Common Stock
S - Sale X -567 127,891 -0.44 144.32 -81,829 18,457,050
2021-12-22 2021-12-20 4 SGEN Seagen Inc.
Common Stock
S - Sale X -345 128,458 -0.27 149.85 -51,698 19,249,431
2021-11-05 2021-11-04 4 SGEN Seagen Inc.
Incentive Stock Option (right to buy)
M - Exercise -2,156 0 -100.00
2021-11-05 2021-11-04 4 SGEN Seagen Inc.
Common Stock
M - Exercise 2,156 128,803 1.70 46.37 99,974 5,972,595
2021-11-05 2021-11-03 4 SGEN Seagen Inc.
Non-Qualified Stock Option (right to buy)
M - Exercise -40,232 0 -100.00
2021-11-05 2021-11-03 4 SGEN Seagen Inc.
Common Stock
S - Sale X -40,232 126,647 -24.11 185.00 -7,442,920 23,429,695
2021-11-05 2021-11-03 4 SGEN Seagen Inc.
Common Stock
M - Exercise 40,232 166,879 31.77 44.09 1,773,829 7,357,695
2021-11-02 2021-10-29 4 SGEN Seagen Inc.
Non-Qualified Stock Option (right to buy)
M - Exercise -33,564 0 -100.00
2021-11-02 2021-10-29 4 SGEN Seagen Inc.
Common Stock
S - Sale X -33,564 126,647 -20.95 180.00 -6,041,523 22,796,473
2021-11-02 2021-10-29 4 SGEN Seagen Inc.
Common Stock
M - Exercise 33,564 160,211 26.50 41.04 1,377,467 6,575,059
2021-09-27 2021-09-23 4 SGEN Seagen Inc.
Common Stock
A - Award 201 126,647 0.16 166.22 33,410 21,051,264
2021-09-02 2021-08-31 4 SGEN Seagen Inc.
Common Stock
S - Sale X -2,122 126,446 -1.65 167.52 -355,468 21,181,665
2021-09-02 2021-08-31 4 SGEN Seagen Inc.
Common Stock
S - Sale X -1,865 128,568 -1.43 167.52 -312,416 21,537,133
2021-08-18 2021-08-16 4 SGEN Seagen Inc.
Non-Qualified Stock Option (right to buy)
A - Award 26,427 26,427
2021-08-18 2021-08-16 4 SGEN Seagen Inc.
Incentive Stock Option (right to buy)
A - Award 642 642
2021-08-18 2021-08-16 4 SGEN Seagen Inc.
Common Stock
A - Award 11,095 130,433 9.30
2021-08-18 2021-08-16 4 SGEN Seagen Inc.
Common Stock
S - Sale X -533 119,338 -0.44 154.55 -82,377 18,444,165
2021-05-13 2021-05-11 4 NLTX Neoleukin Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 25,000 25,000
2020-12-18 2020-12-18 4 SGEN Seagen Inc.
Non-Qualified Stock Option (right to buy)
M - Exercise -33,669 0 -100.00
2020-12-18 2020-12-18 4 SGEN Seagen Inc.
Incentive Stock Option (right to buy)
M - Exercise -1,104 0 -100.00
2020-12-18 2020-12-18 4 SGEN Seagen Inc.
Common Stock
M - Exercise 1,104 119,871 0.93 45.30 50,011 5,430,156
2020-12-18 2020-12-18 4 SGEN Seagen Inc.
Common Stock
S - Sale X -33,669 118,767 -22.09 200.00 -6,733,800 23,753,400
2020-12-18 2020-12-18 4 SGEN Seagen Inc.
Common Stock
M - Exercise 33,669 152,436 28.35 26.10 878,761 3,978,580
2020-11-09 2020-11-05 4 SGEN Seagen Inc.
Common Stock
S - Sale -7,509 118,767 -5.95 180.37 -1,354,383 21,421,766
2020-09-02 2020-09-01 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -469 126,276 -0.37 159.33 -74,726 20,119,555
2020-09-02 2020-09-01 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -50 126,745 -0.04 157.82 -7,891 20,002,896
2020-09-02 2020-09-01 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -1,640 126,795 -1.28 156.87 -257,267 19,890,332
2020-09-02 2020-09-01 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -5,480 128,435 -4.09 155.74 -853,455 20,002,467
2020-09-02 2020-09-01 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -4,452 133,915 -3.22 155.25 -691,173 20,790,304
2020-09-02 2020-08-31 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -2,122 138,367 -1.51 155.69 -330,383 21,542,939
2020-09-02 2020-08-31 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -2,065 140,489 -1.45 155.69 -321,509 21,873,322
2020-08-20 2020-08-18 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -9,262 142,554 -6.10 158.17 -1,464,959 22,547,595
2020-08-17 2020-08-17 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 20,774 20,774
2020-08-17 2020-08-17 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
A - Award 636 636
2020-08-17 2020-08-17 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 8,635 151,816 6.03
2020-08-05 2020-08-03 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -1,905 143,181 -1.31 166.74 -317,640 23,874,000
2020-08-05 2020-08-03 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -10,375 145,086 -6.67 166.10 -1,723,288 24,098,785
2020-08-05 2020-08-03 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -7,720 155,461 -4.73 164.96 -1,273,491 25,644,847
2020-07-02 2020-07-01 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -1,010 163,181 -0.62 171.39 -173,104 27,967,592
2020-07-02 2020-07-01 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -139 164,191 -0.08 170.18 -23,655 27,942,024
2020-07-02 2020-07-01 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -5,012 164,330 -2.96 167.66 -840,312 27,551,568
2020-07-02 2020-07-01 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -4,112 169,342 -2.37 166.99 -686,663 28,278,421
2020-07-02 2020-07-01 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -1,300 173,454 -0.74 165.86 -215,618 28,769,080
2020-05-07 2020-05-05 4 NLTX Neoleukin Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 25,000 25,000
2020-05-06 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -26,867 0 -100.00
2020-05-06 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise -1,103 0 -100.00
2020-05-06 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise -2,268 0 -100.00
2020-05-06 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise -2,436 0 -100.00
2020-05-06 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise -2,554 0 -100.00
2020-05-06 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise -3,831 0 -100.00
2020-05-06 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 3,831 173,888 2.25 26.10 99,989 4,538,477
2020-05-06 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 2,436 170,057 1.45 41.04 99,973 6,979,139
2020-05-06 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 2,268 167,621 1.37 44.09 99,996 7,390,410
2020-05-06 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 2,554 165,353 1.57 39.15 99,989 6,473,570
2020-05-06 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 1,103 162,799 0.68 45.30 49,966 7,374,795
2020-05-06 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -1,200 161,696 -0.74 164.10 -196,920 26,534,314
2020-05-06 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -12,167 162,896 -6.95 163.36 -1,987,601 26,610,691
2020-05-06 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -13,500 175,063 -7.16 162.45 -2,193,075 28,438,984
2020-05-06 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 26,867 188,563 16.62 15.46 415,364 2,915,184
2020-05-06 2020-05-04 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -14,167 0 -100.00
2020-05-06 2020-05-04 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -14,167 161,696 -8.06 147.00 -2,082,556 23,769,393
2020-05-06 2020-05-04 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 14,167 175,863 8.76 12.00 170,004 2,110,356
2020-04-21 2020-04-21 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
D - Sale to Issuer X -570 161,696 -0.35 139.92 -79,752 22,623,906
2020-04-21 2020-04-19 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 1,439 162,266 0.89
2020-04-21 2020-04-19 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 2,389 160,827 1.51
2019-12-23 2019-12-19 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 871 158,438 0.55
2019-10-15 2019-10-10 4 NLTX Neoleukin Therapeutics, Inc.
Stock Option (right to buy)
A - Award 22,000 22,000
2019-10-02 2019-09-30 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -15,000 157,567 -8.69 85.00 -1,275,000 13,393,195
2019-09-04 2019-09-03 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -2,092 172,567 -1.20 70.80 -148,112 12,217,623
2019-09-04 2019-08-30 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 49,232 49,232
2019-09-04 2019-08-30 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
A - Award 1,333 1,333
2019-09-04 2019-08-30 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 21,288 174,659 13.88
2019-08-30 2019-08-28 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -5,909 153,371 -3.71 73.21 -432,624 11,228,966
2019-08-22 2019-08-20 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -12,500 159,280 -7.28 80.00 -1,000,000 12,742,400
2019-04-09 2019-04-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -10,437 171,780 -5.73 78.00 -814,086 13,398,840
2019-04-09 2019-04-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -2,063 182,217 -1.12 78.00 -160,914 14,212,926
2019-03-06 2019-03-04 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -10,000 184,280 -5.15 75.00 -750,000 13,821,000
2018-09-04 2018-08-30 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 47,904 47,904
2018-09-04 2018-08-30 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
A - Award 1,301 1,301
2018-09-04 2018-08-30 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 20,715 194,280 11.94
2018-08-29 2018-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -5,427 173,565 -3.03 74.23 -402,856 12,884,042
2018-05-09 2018-05-07 4 AQXP AQUINOX PHARMACEUTICALS, INC
Stock Option (Right to Buy)
A - Award 15,000 15,000
2018-03-22 2018-03-20 4 SGEN SEATTLE GENETICS INC /WA
Non-qualified Stock Option (Right to buy)
A - Award 10,526 10,526
2017-11-03 2017-11-01 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -534 178,992 -0.30 61.59 -32,889 11,024,117
2017-11-03 2017-11-01 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -38,851 179,526 -17.79 60.90 -2,366,026 10,933,133
2017-09-08 2017-09-06 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -9,638 218,377 -4.23 52.00 -501,176 11,355,604
2017-08-30 2017-08-28 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -4,937 228,015 -2.12 47.89 -236,455 10,920,664
2017-08-18 2017-08-17 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 55,344 55,344
2017-08-18 2017-08-17 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
A - Award 2,156 2,156
2017-08-18 2017-08-17 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 23,000 232,952 10.95
2017-05-10 2017-05-08 4 AQXP AQUINOX PHARMACEUTICALS, INC
Stock Option (Right to Buy)
A - Award 9,000 9,000
2016-08-30 2016-08-27 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 42,793 42,793
2016-08-30 2016-08-27 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
A - Award 2,207 2,207
2016-08-30 2016-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 18,000 209,445 9.40
2016-08-22 2016-08-22 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -3,991 191,445 -2.04 46.59 -185,943 8,919,557
2016-05-11 2016-05-09 4 AQXP AQUINOX PHARMACEUTICALS, INC
Stock Option (Right to Buy)
A - Award 7,500 7,500
2015-10-01 2015-09-29 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise -6,468 0 -100.00
2015-10-01 2015-09-29 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise -8,333 0 -100.00
2015-10-01 2015-09-29 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 8,333 194,675 4.47 12.00 99,996 2,336,100
2015-10-01 2015-09-29 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 6,468 186,342 3.60 15.46 99,995 2,880,847
2015-08-25 2015-08-25 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 39,946 39,946
2015-08-25 2015-08-25 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
A - Award 2,554 2,554
2015-08-25 2015-08-25 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 17,000 179,874 10.44
2015-08-25 2015-08-20 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -5,825 162,874 -3.45 42.02 -244,794 6,844,731
2015-03-16 2015-03-12 4 AQXP AQUINOX PHARMACEUTICALS, INC
Stock Option (Right to Buy)
A - Award 5,000 5,000
2014-08-27 2014-08-26 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 40,232 40,232
2014-08-27 2014-08-26 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
A - Award 2,268 2,268
2014-08-27 2014-08-26 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 17,000 168,699 11.21
2014-08-27 2014-08-24 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -3,696 151,699 -2.38 43.55 -160,957 6,606,340
2014-03-10 2014-03-06 4 AQXP AQUINOX PHARMACEUTICALS, INC
Stock Option (Right to Buy)
A - Award 8,333 8,333
2014-03-06 3 AQXP AQUINOX PHARMACEUTICALS, INC
No securities are beneficially owned
0
2013-08-30 2013-08-28 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise -8,223 0 -100.00
2013-08-30 2013-08-28 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise -9,017 0 -100.00
2013-08-30 2013-08-28 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise -13,126 0 -100.00
2013-08-30 2013-08-28 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 8,223 155,395 5.59 12.16 99,992 1,889,603
2013-08-30 2013-08-28 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 9,017 147,172 6.53 11.09 99,999 1,632,137
2013-08-30 2013-08-28 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 13,126 138,155 10.50 10.29 135,067 1,421,615
2013-08-30 2013-08-27 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -12,500 21,169 -37.13
2013-08-30 2013-08-27 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -12,500 21,169 -37.13
2013-08-30 2013-08-27 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -4,166 26,867 -13.42
2013-08-30 2013-08-27 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -2,972 0 -100.00
2013-08-30 2013-08-27 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -5,625 14,167 -28.42
2013-08-30 2013-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -12,500 125,029 -9.09 41.45 -518,095 5,182,152
2013-08-30 2013-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -12,500 125,029 -9.09 41.45 -518,095 5,182,152
2013-08-30 2013-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 12,500 137,529 10.00 26.10 326,250 3,589,507
2013-08-30 2013-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 12,500 137,529 10.00 26.10 326,250 3,589,507
2013-08-30 2013-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -4,166 125,029 -3.22 41.45 -172,671 5,182,152
2013-08-30 2013-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 4,166 129,195 3.33 15.46 64,406 1,997,355
2013-08-30 2013-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -5,625 125,029 -4.31 41.45 -233,143 5,182,152
2013-08-30 2013-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 5,625 130,654 4.50 12.00 67,500 1,567,848
2013-08-30 2013-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -2,972 125,029 -2.32 41.45 -123,182 5,182,152
2013-08-30 2013-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 2,972 128,001 2.38 12.16 36,140 1,556,492
2013-08-21 2013-08-19 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 33,564 33,564 41.04 1,377,467 1,377,467
2013-08-21 2013-08-19 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
A - Award 2,436 2,436 41.04 99,973 99,973
2013-08-21 2013-08-19 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 14,400 125,029 13.02
2013-08-21 2013-08-19 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -3,328 110,629 -2.92 40.91 -136,148 4,525,832
2013-07-15 2013-07-12 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -29,166 31,033 -48.45
2013-07-15 2013-07-12 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -18,361 19,792 -48.12
2013-07-15 2013-07-12 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -29,166 113,957 -20.38 37.94 -1,106,558 4,323,529
2013-07-15 2013-07-12 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 29,166 143,123 25.59 15.46 450,906 2,212,682
2013-07-15 2013-07-12 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -18,361 113,957 -13.88 37.94 -696,616 4,323,529
2013-07-15 2013-07-12 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 18,361 132,318 16.11 12.00 220,332 1,587,816
2013-07-15 2013-07-11 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -1,486 2,972 -33.33
2013-07-15 2013-07-11 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -43,514 38,153 -53.28
2013-07-15 2013-07-11 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -43,514 113,957 -27.63 36.94 -1,607,407 4,209,572
2013-07-15 2013-07-11 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 43,514 157,471 38.18 12.00 522,168 1,889,652
2013-07-15 2013-07-11 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -1,486 113,957 -1.29 36.94 -54,893 4,209,572
2013-07-15 2013-07-11 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 1,486 115,443 1.30 12.16 18,070 1,403,787
2013-03-08 2013-03-07 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -19,494 4,458 -81.39
2013-03-08 2013-03-07 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -682 0 -100.00
2013-03-08 2013-03-07 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -19,494 113,957 -14.61 30.70 -598,466 3,498,480
2013-03-08 2013-03-07 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 19,494 133,451 17.11 12.16 237,047 1,622,764
2013-03-08 2013-03-07 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -682 113,957 -0.59 30.70 -20,937 3,498,480
2013-03-08 2013-03-07 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 682 114,639 0.60 11.09 7,563 1,271,347
2013-03-08 2013-03-07 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -29,542 113,957 -20.59 30.78 -909,303 3,507,596
2012-11-09 2012-11-08 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise -417 0 -100.00
2012-11-09 2012-11-08 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise -72,320 0 -100.00
2012-11-09 2012-11-08 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 417 143,499 0.29 5.63 2,348 807,899
2012-11-09 2012-11-08 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 72,320 143,082 102.20 5.20 376,064 744,026
2012-09-07 2012-09-06 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -50,000 23,952 -67.61
2012-09-07 2012-09-06 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -50,000 70,762 -41.40 28.97 -1,448,500 2,049,975
2012-09-07 2012-09-06 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 50,000 120,762 70.66 12.16 608,000 1,468,466
2012-09-07 2012-09-05 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -2,825 73,952 -3.68
2012-09-07 2012-09-05 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -42,175 682 -98.41
2012-09-07 2012-09-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -2,825 70,762 -3.84 27.97 -79,015 1,979,213
2012-09-07 2012-09-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 2,825 73,587 3.99 12.16 34,352 894,818
2012-09-07 2012-09-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -42,175 70,762 -37.34 27.97 -1,179,635 1,979,213
2012-09-07 2012-09-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 42,175 112,937 59.60 11.09 467,721 1,252,471
2012-08-27 2012-08-27 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -13,126 42,857 -23.45
2012-08-27 2012-08-27 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -17,874 0 -100.00
2012-08-27 2012-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -13,126 70,762 -15.65 26.97 -354,008 1,908,451
2012-08-27 2012-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 13,126 83,888 18.55 11.09 145,567 930,318
2012-08-27 2012-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -17,874 70,762 -20.17 26.97 -482,062 1,908,451
2012-08-27 2012-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 17,874 88,636 25.26 10.29 183,923 912,064
2012-08-27 2012-08-24 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -14,000 17,874 -43.92
2012-08-27 2012-08-24 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -14,000 70,762 -16.52 26.97 -377,580 1,908,451
2012-08-27 2012-08-24 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 14,000 84,762 19.78 10.29 144,060 872,201
2012-08-22 2012-08-20 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 46,169 46,169 26.10 1,205,011 1,205,011
2012-08-22 2012-08-20 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
A - Award 3,831 3,831 26.10 99,989 99,989
2012-08-22 2012-08-20 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 20,000 70,762 39.40
2012-08-20 2012-08-16 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -40,000 31,874 -55.65
2012-08-20 2012-08-16 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -40,000 50,762 -44.07 25.97 -1,038,800 1,318,289
2012-08-20 2012-08-16 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 40,000 90,762 78.80 10.29 411,600 933,941
2012-06-14 2012-06-14 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -19,583 0 -100.00
2012-06-14 2012-06-14 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -30,417 0 -100.00
2012-06-14 2012-06-14 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -19,583 50,762 -27.84 24.97 -488,988 1,267,527
2012-06-14 2012-06-14 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 19,583 70,345 38.58 5.63 110,252 396,042
2012-06-14 2012-06-14 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -30,417 50,762 -37.47 24.97 -759,512 1,267,527
2012-06-14 2012-06-14 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 30,417 81,179 59.92 5.20 158,168 422,131
2012-06-14 2012-06-12 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -45,000 30,417 -59.67
2012-06-14 2012-06-12 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -45,000 50,762 -46.99 23.97 -1,078,785 1,216,917
2012-06-14 2012-06-12 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 45,000 95,762 88.65 5.20 234,000 497,962
2012-06-08 2012-06-08 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -35,000 75,417 -31.70
2012-06-08 2012-06-08 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -35,000 50,762 -40.81 22.97 -803,950 1,166,003
2012-06-08 2012-06-08 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 35,000 85,762 68.95 5.20 182,000 445,962
2006-02-01 2006-01-31 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 19,583 19,583 5.63 110,252 110,252
2006-02-01 2006-01-31 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
A - Award 417 417 5.63 2,348 2,348
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)